We are driven by the desire to properly test and translate therapies for pediatric applications.  

 

Much like younger siblings forced to make do with hand-me-downs, pediatricians are frequently forced to utilize drugs designed for adults. This can expose patients to potential harm and pediatricians to additional risk.

 

A "one-stop-shop" for any investigator, biotech or pharmaceutical company that wishes to develop their therapy, device or diagnostic specifically for pediatric applications. 

Experts in pediatrics, pharmacology and regulatory oversight provide guidance on preclinical as well as clinical study design.

Directors

 

gobburu.jpg

Joga Gobburu, PhD, MBA
Executive Director

 

Emin Maltepe, MD, PhD
Director, Product Development

Janel Long-Boyle, PharmD, PhD
Director, Clinical Trials

  Joga Gobburu, PharmD, MBA              Director

Jeff Fineman, MD
 Director, Pre-Clinical Development

iPD3-logo (4).png
  Vijay Ivaturi, PhD   Director, Clinical Pharmacology

Vijay Ivaturi, PhD

Director, Clinical Pharmacology

 

 

Interested in working together? Here's our contact info.

 

Initiative for Pediatric Drug and Device development

iPD3

550 16th St.

San Francisco, CA 94158